Allison Cole - Publications
Affiliations: | 2018- | Pediatrics | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Marquardt V, Theruvath J, Pauck D, Picard D, Qin N, Blümel L, Maue M, Bartl J, Ahmadov U, Langini M, Meyer FD, Cole A, Cruz-Cruz J, Graef CM, Wölfl M, et al. Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation. Journal For Immunotherapy of Cancer. 11. PMID 36639156 DOI: 10.1136/jitc-2022-005871 | 0.361 | |||
2021 | Lakshmanachetty S, Cruz-Cruz J, Hoffmeyer E, Cole AP, Mitra SS. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs. Cells. 10. PMID 33919732 DOI: 10.3390/cells10040893 | 0.403 | |||
2020 | Cole AP, Hoffmeyer E, Chetty SL, Cruz-Cruz J, Hamrick F, Youssef O, Cheshier S, Mitra SS. Microglia in the Brain Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1273: 197-208. PMID 33119883 DOI: 10.1007/978-3-030-49270-0_11 | 0.387 | |||
Show low-probability matches. |